103 related articles for article (PubMed ID: 35801418)
21. Joint association of polymorphism of the FGFR4 gene and mutation TP53 gene with bladder cancer prognosis.
Yang YC; Lu ML; Rao JY; Wallerand H; Cai L; Cao W; Pantuck A; Dalbagni G; Reuter V; Figlin RA; Belldegrun A; Cordon-Cardo C; Zhang ZF
Br J Cancer; 2006 Dec; 95(11):1455-8. PubMed ID: 17088904
[TBL] [Abstract][Full Text] [Related]
22. Loss of heterozygosity and DNA methylation affect germline fibroblast growth factor receptor 4 polymorphism to direct allelic selection in breast cancer.
Zhu X; Zheng L; Asa SL; Ezzat S
Am J Pathol; 2010 Dec; 177(6):2860-9. PubMed ID: 21037081
[TBL] [Abstract][Full Text] [Related]
23. Anastomosing Haemangioma: Report of Three Cases With Molecular and Immunohistochemical Studies and Comparison With Well-Differentiated Angiosarcoma.
Chang Chien YC; Beke L; Méhes G; Mokánszki A
Pathol Oncol Res; 2022; 28():1610498. PubMed ID: 35979530
[TBL] [Abstract][Full Text] [Related]
24. Angiosarcoma heterogeneity and potential therapeutic vulnerability to immune checkpoint blockade: insights from genomic sequencing.
Boichard A; Wagner MJ; Kurzrock R
Genome Med; 2020 Jul; 12(1):61. PubMed ID: 32646514
[TBL] [Abstract][Full Text] [Related]
25. Fibroblast growth factor receptor 4 polymorphisms and susceptibility to coronary artery disease.
Ma L; Zhang H; Han C; Tong D; Zhang M; Yao Y; Luo Y; Liu X
DNA Cell Biol; 2012 Jun; 31(6):1064-9. PubMed ID: 22313031
[TBL] [Abstract][Full Text] [Related]
26. Correlation of telomere length shortening with TP53 somatic mutations, polymorphisms and allelic loss in breast tumors and esophageal cancer.
Hao XD; Yang Y; Song X; Zhao XK; Wang LD; He JD; Kong QP; Tang NL; Zhang YP
Oncol Rep; 2013 Jan; 29(1):226-36. PubMed ID: 23124483
[TBL] [Abstract][Full Text] [Related]
27. Genetic alterations in sporadic triple negative breast cancer.
Pop LA; Cojocneanu-Petric RM; Pileczki V; Morar-Bolba G; Irimie A; Lazar V; Lombardo C; Paradiso A; Berindan-Neagoe I
Breast; 2018 Apr; 38():30-38. PubMed ID: 29202330
[TBL] [Abstract][Full Text] [Related]
28. Actionable mutations in canine hemangiosarcoma.
Wang G; Wu M; Maloneyhuss MA; Wojcik J; Durham AC; Mason NJ; Roth DB
PLoS One; 2017; 12(11):e0188667. PubMed ID: 29190660
[TBL] [Abstract][Full Text] [Related]
29. Genetic Heterogeneity in Therapy-Naïve Synchronous Primary Breast Cancers and Their Metastases.
Ng CKY; Bidard FC; Piscuoglio S; Geyer FC; Lim RS; de Bruijn I; Shen R; Pareja F; Berman SH; Wang L; Pierga JY; Vincent-Salomon A; Viale A; Norton L; Sigal B; Weigelt B; Cottu P; Reis-Filho JS
Clin Cancer Res; 2017 Aug; 23(15):4402-4415. PubMed ID: 28351929
[No Abstract] [Full Text] [Related]
30. A case report of angiosarcoma of the tongue: A diagnostic dilemma at presentation.
Bhattacharya S; Koshy AV; Baldawa P; Thakur S; Shah A; Bhagwat H
Indian J Dent Res; 2023; 34(2):226-228. PubMed ID: 37787218
[TBL] [Abstract][Full Text] [Related]
31. Effects of DLC1 Deficiency on Endothelial Cell Contact Growth Inhibition and Angiosarcoma Progression.
Sánchez-Martín D; Otsuka A; Kabashima K; Ha T; Wang D; Qian X; Lowy DR; Tosato G
J Natl Cancer Inst; 2018 Apr; 110(4):390-399. PubMed ID: 29202196
[TBL] [Abstract][Full Text] [Related]
32. A rare case of highly differentiated follicular carcinoma in ovary with FGFR4 Gly388Arg polymorphism: a case report and literature review.
Bao YT; Wang C; Huang W; Yao LQ; Yuan L
J Ovarian Res; 2022 Jun; 15(1):71. PubMed ID: 35701820
[TBL] [Abstract][Full Text] [Related]
33. A mutation in the POT1 gene is responsible for cardiac angiosarcoma in TP53-negative Li-Fraumeni-like families.
Calvete O; Martinez P; Garcia-Pavia P; Benitez-Buelga C; Paumard-Hernández B; Fernandez V; Dominguez F; Salas C; Romero-Laorden N; Garcia-Donas J; Carrillo J; Perona R; Triviño JC; Andrés R; Cano JM; Rivera B; Alonso-Pulpon L; Setien F; Esteller M; Rodriguez-Perales S; Bougeard G; Frebourg T; Urioste M; Blasco MA; Benítez J
Nat Commun; 2015 Sep; 6():8383. PubMed ID: 26403419
[TBL] [Abstract][Full Text] [Related]
34. [Radiation-induced breast angiosarcoma: about a case].
Majdoubi A; Serji B; Harroudi TE
Pan Afr Med J; 2020; 36():29. PubMed ID: 32774606
[TBL] [Abstract][Full Text] [Related]
35. KDR activating mutations in human angiosarcomas are sensitive to specific kinase inhibitors.
Antonescu CR; Yoshida A; Guo T; Chang NE; Zhang L; Agaram NP; Qin LX; Brennan MF; Singer S; Maki RG
Cancer Res; 2009 Sep; 69(18):7175-9. PubMed ID: 19723655
[TBL] [Abstract][Full Text] [Related]
36. Tumour suppressor gene TP53 mutations in atypical vascular lesions of breast skin following radiotherapy.
Santi R; Cetica V; Franchi A; Pepi M; Cesinaro AM; Miracco C; Paglierani M; De Giorgi V; Delfino C; Difonzo EM; Pimpinelli N; Bianchi S; Sardi I; Santucci M; Massi D
Histopathology; 2011 Feb; 58(3):455-66. PubMed ID: 21323968
[TBL] [Abstract][Full Text] [Related]
37. Clinical, genomic, and transcriptomic correlates of response to immune checkpoint blockade-based therapy in a cohort of patients with angiosarcoma treated at a single center.
Rosenbaum E; Antonescu CR; Smith S; Bradic M; Kashani D; Richards AL; Donoghue M; Kelly CM; Nacev B; Chan JE; Chi P; Dickson MA; Keohan ML; Gounder MM; Movva S; Avutu V; Thornton K; Zehir A; Bowman AS; Singer S; Tap W; D'Angelo S
J Immunother Cancer; 2022 Apr; 10(4):. PubMed ID: 35365586
[TBL] [Abstract][Full Text] [Related]
38. MDM-2 oncoprotein overexpression, p53 gene mutation, and VEGF up-regulation in angiosarcomas.
Zietz C; Rössle M; Haas C; Sendelhofert A; Hirschmann A; Stürzl M; Löhrs U
Am J Pathol; 1998 Nov; 153(5):1425-33. PubMed ID: 9811333
[TBL] [Abstract][Full Text] [Related]
39. Significance of TP53 mutations determined by next-generation "deep" sequencing in prognosis of estrogen receptor-positive breast cancer.
Uji K; Naoi Y; Kagara N; Shimoda M; Shimomura A; Maruyama N; Shimazu K; Kim SJ; Noguchi S
Cancer Lett; 2014 Jan; 342(1):19-26. PubMed ID: 23973262
[TBL] [Abstract][Full Text] [Related]
40. Biallelic
Hanna JA; Drummond CJ; Garcia MR; Go JC; Finkelstein D; Rehg JE; Hatley ME
Cancer Res; 2017 Nov; 77(22):6109-6118. PubMed ID: 28916654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
